Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
22,169,198
-
Share change
-
-1,043,214
-
Total reported value
-
$2,159,297,534
-
Put/Call ratio
-
70%
-
Price per share
-
$97.42
-
Number of holders
-
181
-
Value change
-
-$198,458,474
-
Number of buys
-
92
-
Number of sells
-
112
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q3 2020
As of 30 Sep 2020,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
181 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,169,198 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, CPMG Inc, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Invesco Ltd., Duquesne Family Office LLC, FMR LLC, and PICTET ASSET MANAGEMENT LTD.
This page lists
181
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.